Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Continued funding for research on cell death

08.11.2016

3.5 million euros for tri-national research unit on the modulation of programmed cell death

Programmed cell death is a basic pre-requisite for life, and its underlying mechanisms are immensely interesting not only for cancer research. The tri-national research unit FOR2036, whose speaker is Professor Thomas Brunner (professor of biochemical pharmacology) of the University of Konstanz, includes scientists from Germany, Switzerland and Austria.

Since 2014 they have studied how the programmed cell death, the so-called apoptosis, is being regulated. That the research unit is on the right track has now been confirmed: the German Research Foundation (DFG) and the Austrian Science Fund (FWF) will continue to fund the research unit, consisting of nine sub-projects, with 3.4 million euros over the next three years.

The complex functional network of the so-called Bcl-2 family proteins plays a central role in modulating the programmed cell death. The name of the research unit "New insights into Bcl-2 family interactions: from biophysics to function" indicates that the teams deal with the question on different levels.

The research spectrum ranges from in vitro approaches of biophysics and biochemistry to cell biological or system biological processes, as well as clinical methods and approaches where the cells of tumour patients are examined on their characteristic pattern of Bcl-2 proteins and cell death. "The considerable resources in this consortium allow us to initiate projects quickly and flexibly", says Thomas Brunner about the synergies in the joint research project.

Why programmed cell death?
Our immune system shows us how important it is to rid of unwanted cells through apoptosis: after recovering from an infection, programmed cell death will adjust the number of granulocytes or lymphocytes to a normal level. This cell death induction seems to no longer function in leukemia cells. Therefore one of the most central questions in tumour research is how to influence the network of the Bcl-2 family. Its "family members" can prevent or promote cell death - the corresponding interaction is decisive. Cell death is triggered by certain molecules (called Bax and Bak) that form pores in the mitochondrial outer membrane of the cell, which in turn initiates apoptosis induction. One of the goals in tumour therapy is to positively influence the pore-forming effect.

Basic research implemented in clinical practice
So-called BH3-molecules can constrain Bcl-2-homologues that are conducive for survival and are found in larger numbers in many tumour cells. A new class of molecules developed by research is able to mimic BH3-molecules ("BH3 mimetics"). They, too, promote the formation of pores and thus cell death. "This year this new class of substances was approved by the US-American Food and Drug Administration (FDA) for the treatment of certain types of leukemia. This is one of the examples where basic research gained a foothold in clinical practice very quickly. One of our colleagues, PD Dr. Philipp Jost at the hospital "Klinikum rechts der Isar" of the Technical University in Munich will be involved in these clinical studies", explains Thomas Brunner.

Pores made visible for the first time
Another highlight for the research unit is that Professor Ana García-Sáez (University of Tübingen), using high-resolution microscopy, now succeeded in visualizing pores, which had been postulated before only on the basis of calculations and biochemical tests. The bio-physical research methods are very reductionistic and make it possible to study these proteins nearly on a physical level. This was an extremely important approach for various members of this research unit", explains Thomas Brunner.

University of Konstanz: mathematical models make predictions possible
Team members at the University of Konstanz work on mathematically tracking the complex pattern of possible interactions. Professor Tancred Frickey and doctoral student Annika Hantusch, in cooperation with Thomas Brunner and Professor Markus Morrison from Tübingen, develop model systems that can simulate the interactions of the family members. This will enable the researchers to predict how a cell with a certain pattern of Bcl-2-homologs will react to certain chemotherapeutic substances. "We have made huge progress in developing the mathematical model, and we have also collected data that is available in the expert literature in one online data base. These interactions can directly be searched for on the corresponding website of the University of Konstanz." In the future, mathematical analysis might predict whether a patient will react positively to a certain treatment without actually having to burden the patient with drugs that will probably be ineffective.

Facts:
The research unit "New insights into Bcl-2 family interactions: from biophysics to function" (FOR 2036) was funded by the German Research Foundation (DFG), the Austrian Science Fund (FWF) and the Swiss National Science Foundation (SNF) from 2013–2016. For the second funding period 2017–2020 the DFG and the FWF will support the consortium with a total of 3.5 euros. Professor Thomas Brunner, chair of biochemical pharmacology at the University of Konstanz, is the speaker of the Konstanz-based research unit.
Institutions and members:
University of Konstanz (Germany): Professor Thomas Brunner
University of Freiburg (Germany): Dr. Miriam Erlacher, Professor Christoph Borner, Professor Georg Häcker
University of Tübingen (Germany): Professor Ana García Sáez
Technical University of Munich (Germany): PD Dr. Philipp Jost
University of Stuttgart (Germany): Professor Markus Morrison (-Rehm)
University hospitals Salzburg (Austria): PD Dr. Alexander Egle
Innsbruck Medical University (Austria): Professor Andreas Villunger
University of Bern (Switzerland): Professor Thomas Kaufmann (associated)

https://cms.uni-konstanz.de/fileadmin/pi/fileserver/2016/Brunner-Uni-KN-2016.jpg
Professor Thomas Brunner

https://cms.uni-konstanz.de/fileadmin/pi/fileserver/2016/cytcGFP_release_highlig...
Microscopic evidence of cytochrome c-release during apoptosis. On the left a group of liver cancer cells that still hold cytochrome c (green) in the mitochondria; on the right the same cells 5 minutes later with a cell (arrow) which already has spilled its cytochrome c into the cytoplasm and will now die.

https://cms.uni-konstanz.de/fileadmin/pi/fileserver/2016/Bcl-2-Ome.png
The web-based data base "Bcl-2-ome" on Bcl-2-family-interactions (for2036.uni-konstanz.de/Bcl2Ome/index.php)

Contact
University of Konstanz
Communications and Marketing
Phone: + 49 7531 88-3603
E-Mail: kum@uni-konstanz.de

Julia Wandt | idw - Informationsdienst Wissenschaft
Further information:
http://www.uni-konstanz.de

Further reports about: DFG apoptosis cell death pores programmed cell death proteins tumour

More articles from Awards Funding:

nachricht Innovation Award of the United Nations Environment Programme for PhD Student from ZMT
22.03.2018 | Leibniz-Zentrum für Marine Tropenforschung (ZMT)

nachricht ERC Project set to boost application of adhesive structures
19.03.2018 | INM - Leibniz-Institut für Neue Materialien gGmbH

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>